Turbo Cancers: What Does the Research Reveal?

  • Turbo Cancers: What Does the Research Reveal?

    Posted by IMA-HelenT on November 11, 2026 at 7:23 am EST

    For anyone in remission, few words land harder than “the cancer is back.” In one six-week stretch, oncologist Professor Angus Dalgleish saw it happen to six of his patients, whose stage 4 cancers had been gone for 3 to 18 years. All six had taken a COVID-19 booster before the cancer returned.

    Since the COVID-19 mRNA injections rolled out, clinicians in several countries have reported the same pattern, and health authorities have been slow to look. Some won’t even acknowledge it: Australia’s drug regulator says flatly that it doesn’t recognize turbo cancers. Experts like pathologist Dr. Ryan Cole and Professor Dalgleish say the tests that could settle the question are simple and cheap, yet rarely run.

    Dr. Cole sits down with Professor Dalgleish and Professor Ian Brighthope, both IMA Senior Fellows, to go through what clinicians are seeing and why they suspect the immune system. If you’re facing cancer now, or caring for someone who is, they also lay out where to start: the foundations that come before any treatment.

    Watch Here: https://imahealth.org/turbo-cancers-clinical-observations-emerging-research-and-patient-care/

    IMA-HelenT replied 2 days, 11 hours ago 1 Member · 1 Reply
  • 1 Reply
  • IMA-HelenT

    Organizer
    November 11, 2026 at 7:25 am EST

    From the UK in light of Prof. Dalgleish joining the show tonight:

    New NHS figures show that cancer diagnoses in England exceeded 1,000 per day in 2024—and nearly 1,700 when common skin cancers are included.

    A new IMA post highlights these figures and shares concerns raised by UK-based Professor Angus Dalgleish, IMA Senior Fellow, Oncology, about aggressive cancers and potential contributing factors.

    https://imahealth.org/england-hits-1000-cancer-diagnoses-a-day-the-nhs-calls-it-progress

Log in to reply.